X4 Pharmaceuticals, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/13/2025

Shares

3,619,682

Value ($000)

856

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/13/2025	856	0.0%	3,619,682	3/31/2025
2024 Q4	2/12/2025	2,566	0.0%	3,497,212	12/31/2024
2024 Q3	11/12/2024	2,308	0.0%	3,447,512	9/30/2024
2024 Q2	8/9/2024	2,039	0.0%	3,515,538	6/30/2024
2024 Q1	5/13/2024	4,095	0.0%	2,945,424	3/31/2024
2023 Q4	2/13/2024	2,350	0.0%	2,802,449	12/31/2023
2023 Q3	11/13/2023	2,881	0.0%	2,642,915	9/30/2023
2023 Q2	8/11/2023	4,559	0.0%	2,350,210	6/30/2023
2023 Q1	5/15/2023	965	0.0%	1,108,684	3/31/2023
2022 Q4	2/13/2023	583	0.0%	587,516	12/31/2022
2022 Q3	11/14/2022	844	0.0%	493,657	9/30/2022
2022 Q2	8/12/2022	182	0.0%	189,548	6/30/2022
2022 Q1	5/13/2022	320	0.0%	183,277	3/31/2022
2021 Q4	2/11/2022	407	0.0%	178,060	12/31/2021
2021 Q3	11/12/2021	941	0.0%	178,060	9/30/2021
2021 Q2	8/13/2021	1,052	0.0%	161,917	6/30/2021
2021 Q1	5/12/2021	2,222	0.0%	258,165	3/31/2021
2020 Q4	2/12/2021	1,648	0.0%	256,454	12/31/2020
2020 Q3	11/13/2020	1,645	0.0%	242,988	9/30/2020
2020 Q2	8/13/2020	2,124	0.0%	227,972	6/30/2020
2020 Q1	5/14/2020	2,094	0.0%	209,419	3/31/2020
2019 Q4	2/13/2020	1,935	0.0%	180,921	12/31/2019